This is a major reason patients compare prescription GLP-1 vs compounded weight loss injections before starting treatment
Secondary signals across both trials reduced knee osteoarthritis pain, fewer obstructive sleep apnea events, improvements in triglycerides, blood pressure, LDL, and hsCRP suggest systemic metabolic remodeling rather than simple caloric suppression
"Perhaps doses that achieve modest weight loss but robust anti-inflammatory and vascular benefits might be appropriate for some indications, while maximum-tolerated doses remain appropriate for obesity," says Nadolsky
Dosing Strategies for Weight Loss Weight Loss Results with Retatrutide Phase 2 trial results by dose: 1mg produced 8.7% weight loss, 4mg hit 17.3%, 8mg reached 22.8%, and the 12mg group lost 24.2% at 48 weeks
Retatrutide half-life Why it is dosed once weekly
Its ability to reduce weight significantly and improve metabolic health makes it a breakthrough therapy